Clinical Trials Directory

Trials / Suspended

SuspendedNCT00184938

Opioid Receptors Influence Ischemia-Reperfusion Injury

Opioid Induced Acute Preconditioning

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Radboud University Medical Center · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The most powerful protective mechanism against ischemia-reperfusion injury other than rapid reperfusion is ischemic preconditioning. Ischemic preconditioning is defined as the development of tolerance to ischemia-reperfusion injury by a previous short bout of ischemia resulting in a marked reduction in infarct size. This mechanism can be mimicked by several pharmacological substances such as adenosine and morphine. We, the researchers at Radboud University Nijmegen Medical Centre, have recently developed a method in which we can detect ischemia-reperfusion injury in the human forearm by using Annexin A5 scintigraphy (Rongen et al). With this method we will determine whether opioid receptors are involved in ischemic preconditioning. We expect to find that morphine can mimic ischemic preconditioning and that acute ischemic preconditioning can be blocked with the opioid receptor antagonist naloxon. This study will increase our knowledge about the mechanism of ischemic preconditioning and may also provide leads to exploit this endogenous protective mechanism in a clinical setting.

Conditions

Interventions

TypeNameDescription
DRUGmorphine
DRUGnaloxone
DRUGTechnetium-TC99m-labeled Annexin A5
PROCEDUREforearm ischemic exercise
PROCEDUREten minute forearm ischemia

Timeline

Start date
2005-01-01
First posted
2005-09-16
Last updated
2008-03-28

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00184938. Inclusion in this directory is not an endorsement.